154 related articles for article (PubMed ID: 6282206)
1. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
Fass RJ
Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
[TBL] [Abstract][Full Text] [Related]
2. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
Fass RJ
Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins.
Chattopadhyay B; Hall I; Curnow SR
J Antimicrob Chemother; 1983 Feb; 11(2):200-1. PubMed ID: 6219982
[No Abstract] [Full Text] [Related]
4. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
Yu PK; Edson RS; Washington JA; Hermans PE
Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Jorgensen JH; Crawford SA; Alexander GA
Antimicrob Agents Chemother; 1980 Jun; 17(6):937-42. PubMed ID: 6250470
[TBL] [Abstract][Full Text] [Related]
6. In vitro interaction between mecillinam and piperacillin-tazobactam in the presence of azithromycin against members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
Maioli E; Debbia EA; Gualco L; Marchese A
New Microbiol; 2008 Jan; 31(1):37-46. PubMed ID: 18437840
[TBL] [Abstract][Full Text] [Related]
7. The in vitro activity of moxalactam against 430 clinical, bacterial isolates.
Digranes A; Benonisen E; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):69-72. PubMed ID: 6211028
[TBL] [Abstract][Full Text] [Related]
8. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
[TBL] [Abstract][Full Text] [Related]
9. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
Chattopadhyay B; Hall I
J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Greenwood D; Eley A; Pearson N; O'Grady F
J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
Verbist L
J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
Goto S
Rev Infect Dis; 1982; 4 Suppl():S501-10. PubMed ID: 6218559
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.
Azimi PH; Dunphy MG
Antimicrob Agents Chemother; 1982 Mar; 21(3):521-4. PubMed ID: 6213193
[TBL] [Abstract][Full Text] [Related]
14. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
15. In-vitro sensitivity to mecillinam of multiresistant gram-negative rods.
Chattopadhyay B; Thomas E
Lancet; 1978 Jan; 1(8057):214-5. PubMed ID: 74642
[No Abstract] [Full Text] [Related]
16. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of antibacterial activity of mecillinam against recently isolated bacilli of 5 genera of Enterobacteriaceae from clinical materials with ampicillin, amoxicillin, cephalexin, nalidixic acid and pipemidic acid (author's transl)].
Kosakai N; Oguri T
Jpn J Antibiot; 1979 Aug; 32(8):812-8. PubMed ID: 226736
[No Abstract] [Full Text] [Related]
18. Inhibitory activity and bactericidal kinetics of mecillinam/ampicillin combinations against Enterobacteriaceae, Pseudomonas and Acinetobacter.
Fuglesang JE; Bergan T; Bielecki T; Naterstad A; Namork E
Infection; 1981; 9(6):290-5. PubMed ID: 6277795
[TBL] [Abstract][Full Text] [Related]
19. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Mintz L; Drew WL
Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
